Bat rabies virus in its natural host
Bat rabies virus in its natural host
批准号:
7847579
负责人:
Matthias Johannes Schnell
金额:
$20.85万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2012-05-31
关键词:
AffectAmericasAnimal HousingAnimal ModelAnimalsAntiviral AgentsAppearanceAutopsyBiological AssayBiologyBiteBloodCanis familiarisCaringChiropteraClinicalDevelopmentDiseaseDomestic AnimalsEbola virusEmerging Communicable DiseasesEquipmentExhibitsExposure toFecesFoundationsFrequenciesGuidelinesHealthHendra VirusHousingHumanImmune responseImmunoglobulinsInfectionIntramuscularLaboratoriesLanguageLifeMaintenanceMammalsMethodsMinorMolecularMolecular VirologyMusNatureNeuronsNew YorkNipah VirusOutcomePathogenesisPathogenicityPeripheralPlayPrevalencePropertyPublic HealthRabiesRabies virusReportingResearch PersonnelRift Valley fever virusRoleRouteSARS coronavirusSalivaSerologicalSilverSiteSwabTestingTimeTissuesUrineVaccinesVariantViralVirusVirus DiseasesVirus SheddingWorkbaseenzooticevidence based guidelinesexperienceimmunogenicitymortalityprogramspublic health relevanceresearch studytransmission processvirus host interaction
中文摘要
描述(由申请人提供):在美洲,蝙蝠是狂犬病毒(RV)的主要宿主,过去20年在美国报告的大多数人类狂犬病病例是由在蝙蝠物种中传播的RV变异引起的。与典型的由患有狂犬病的陆生食肉动物传播的人类狂犬病不同,大多数人类狂犬病病例的发生没有证据表明通过已知的咬伤或抓伤暴露于病毒。然而,对蝙蝠中RV的研究并不充分。根据我们的初步结果,我们对这项研究的总体假设是:在感染了导致美国大多数人类狂犬病病例的蝙蝠狂犬病变体、另一种蝙蝠狂犬病变体或导致陆生食肉动物狂犬病循环的狂犬病病毒变体的蝙蝠中,在病毒传播模式、病毒传播和病毒脱落方面存在显著差异。目的1:在蝙蝠动物模型中比较蝙蝠相关毒株和经典RV毒株的致病性。目标2。研究蝙蝠源性SHBRV在大棕蝠动物模型中的传播、传播方式及免疫原性。这些结果将揭示病毒在蝙蝠群体内传播的可能途径,以及蝙蝠中RV致病性的独特属性,从而支持蝙蝠是RV独特宿主的概念,该宿主在包括人类在内的其他哺乳动物感染中发挥重要作用。因此,这项研究应该有助于理解蝙蝠如何作为新发传染病的宿主。公共卫生相关性:狂犬病毒是一种破坏性的神经元疾病,可影响动物和人类。蝙蝠可能是狂犬病的宿主,对人类健康具有重要影响
英文摘要
DESCRIPTION (provided by applicant): In the Americas, bats represent a major reservoir for rabies virus (RV) and most of the human rabies cases that were reported during the last twenty years in the US were caused by RV variants that circulate in bat species. Unlike the classical human rabies transmission by rabid terrestrial carnivores, most of theses human rabies cases occurred without evidence of exposure to the virus by way of recognized bites or scratches. However, RV in bats is not well studied. Based on our preliminary results, our overall hypothesis for this study is: There are significant differences in regard to mode of virus transmission, viral spread, and virus shedding in bats infected with either the bat rabies variant causing most human rabies cases in the US, another bat rabies variants, or a rabies virus variant causing rabies cycles in terrestrial carnivores. Aim 1: Compare the pathogenicity of bat-associated and classical RV strains in a bat animal model. Aim 2. Study the mode of transmission, spread and immunogenicity of bat-derived SHBRV in the big brown bat animal model. The results should reveal possible routes of virus transmission within bat colonies as well as unique attributes of RV pathogenicity in bats, and therefore support the concept that bats represent a unique reservoir of RV that plays a significant role in the infection of other mammals including humans. Therefore, this study should contribute to an understanding of how bats in general can serve as reservoirs for emerging infectious diseases. PUBLIC HEALTH RELEVANCE: Rabies virus is a devastating neuronal disease, which affects animal and humans. Bats might serve as a reservoir for rabies with important implications for human health
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Toward a protective Covid-19 vaccine utilizing an established vector platform
-
批准号:10170820
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
-
批准号:10078258
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
-
批准号:10311511
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses
-
批准号:9905663
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Matthias Johannes Schnell
-
依托单位:
Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
-
批准号:10465086
-
项目类别:
-
资助金额:$16.49万
-
财政年份:2018
-
负责人:Matthias Johannes Schnell
-
依托单位:
Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer
-
批准号:10201425
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2018
-
负责人:Matthias Johannes Schnell
-
依托单位:
Development of a single-dose rabies virus vaccine
-
批准号:10054163
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2016
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:9205480
-
项目类别:
-
资助金额:$83.14万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8790424
-
项目类别:
-
资助金额:$120.32万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8994257
-
项目类别:
-
资助金额:$109.09万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8496399
-
项目类别:
-
资助金额:$94.97万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine
-
批准号:8608481
-
项目类别:
-
资助金额:$94.51万
-
财政年份:2013
-
负责人:Matthias Johannes Schnell
-
依托单位:
A novel vaccine: botulinum neurotoxin subunit on a viral carrier.
-
批准号:8495212
-
项目类别:
-
资助金额:$85.85万
-
财政年份:2012
-
负责人:Matthias Johannes Schnell
-
依托单位:
A novel vaccine: botulinum neurotoxin subunit on a viral carrier.
-
批准号:8250086
-
项目类别:
-
资助金额:$81.76万
-
财政年份:2012
-
负责人:Matthias Johannes Schnell
-
依托单位:
RABIES VIRUS-BASED VECTORS AS AN HIV-1 VACCINE
-
批准号:8358036
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Matthias Johannes Schnell
-
依托单位:
RABIES VIRUS-BASED VECTORS AS AN HIV-1 VACCINE
-
批准号:8172927
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Matthias Johannes Schnell
-
依托单位:
Bat rabies virus in its natural host
-
批准号:7612601
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
RABIES VIRUS-BASED VECTORS AS AN HIV-1 VACCINE
-
批准号:7958584
-
项目类别:
-
资助金额:$5.81万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
Functional Analysis of NSV-based HIV vectors
-
批准号:7924009
-
项目类别:
-
资助金额:$131.42万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
Functional Analysis of NSV-based HIV vectors
-
批准号:7646605
-
项目类别:
-
资助金额:$136.21万
-
财政年份:2009
-
负责人:Matthias Johannes Schnell
-
依托单位:
海外基金